Daypro (G.D. Searle LLC Division of Pfizer Inc)
Welcome to the PulseAid listing for the Daypro drug offered from G.D. Searle LLC Division of Pfizer Inc. This Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | G.D. Searle LLC Division of Pfizer Inc |
| NON-PROPRIETARY NAME: | oxaprozin |
| SUBSTANCE NAME: | OXAPROZIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1992-10-29 |
| END MARKETING DATE: | 0000-00-00 |
Daypro HUMAN PRESCRIPTION DRUG Details:
| Item Description | Daypro from G.D. Searle LLC Division of Pfizer Inc |
| LABELER NAME: | G.D. Searle LLC Division of Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 600(mg/1) |
| START MARKETING DATE: | 1992-10-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0025-1381_fb232bdf-8642-4790-845a-e0bbd5c936eb |
| PRODUCT NDC: | 0025-1381 |
| APPLICATION NUMBER: | NDA018841 |
Other OXAPROZIN Pharmaceutical Manufacturers / Labelers:
